$3.22
0.010.31%
Pre-Market: 4:08 AM EDT
15 minutes delayed
Comments
Loading...
Latest news for Fulcrum Therapeutics (NASDAQ:FULC) Stock
Fulcrum Therapeutics Stock (NASDAQ: FULC)
Categories: All
Tuesday, September 24, 2024
Friday, September 20, 2024
Friday, September 13, 2024
Thursday, September 12, 2024
- Leerink Partners Downgrades Fulcrum Therapeut...
- Dow Surges Over 100 Points; ModivCare Shares Plummet
- B of A Securities Downgrades Fulcrum Therapeu...
- Stifel Downgrades Fulcrum Therapeutics to Hol...
- Crude Oil Surges 3%; Kroger Posts Upbeat Earnings
- Fulcrum Therapeutics Suspends Rare Muscular Disease Candidate After Disappointing Data From Pivotal Trial
- Cantor Fitzgerald Downgrades Fulcrum Therapeu...
- US Stocks Mixed; Producer Prices Increase In August
- Market-Moving News for September 12th
- Fulcrum Therapeutics shares are trading lower...
- Fulcrum To Suspend Future Losmapimod Developm...
- Fulcrum Therapeutics' Phase 3 REACH Trial Of ...
Monday, September 09, 2024
Friday, September 06, 2024
Tuesday, September 03, 2024
Tuesday, August 20, 2024
Monday, August 19, 2024
Friday, August 09, 2024
Thursday, August 08, 2024
Thursday, August 01, 2024
Wednesday, July 31, 2024
Tuesday, July 16, 2024
Wednesday, July 10, 2024
Tuesday, June 11, 2024
Monday, May 20, 2024
Tuesday, May 14, 2024
Monday, May 13, 2024
- Deep Dive Into Fulcrum Therapeutics Stock: Analyst Perspectives (4 Ratings)
- Goldman Sachs Upgrades Fulcrum Therapeutics t...
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Fulcrum Therapeutics shares are trading highe...
- Fulcrum Therapeutics Expects Cash Balance Of ...
- Fulcrum Therapeutics Q1 2024 GAAP EPS $(0.43)...
- Fulcrum Therapeutics Announces License Agreem...